Color: Jill Hagenkord
Jill Hagenkord is no longer chief medical officer of genetic testing firm Color and has started a new consulting company called MDisrupt. Hagenkord previously held executive positions at Invitae, 23andMe, and Complete Genomics. She co-founded MDisrupt with another 23andMe alum, Ruby Gadelrab, who is serving as CEO. The start-up describes itself as a "medical diligence company" that aims to help companies speed innovative products to market by "assessing a product's clinical and commercial viability in a healthcare setting."